RashmiVermaMDFACP

PubMed

• 1 citations
  High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET.
  Yiran Wang, Yasser G Abdelhafez, Benjamin A Spencer, Rashmi Verma, Mamta Parikh
  Journal of Nuclear Medicine. 2024-05-01
• 9 citations
  Neoadjuvant Cabozantinib in Renal Cell Carcinoma: A Brief Review
  Arya Mariam Roy, Andrew Briggler, Danielle Tippit, Kellen Dawson, Rashmi Verma
  Clinical Genitourinary Cancer. 2020-04-21
• 38 citations
  Sex-Driven Differences in Immunological Responses: Challenges and Opportunities for the Immunotherapies of the Third Millennium
  Leonardo Mirandola, Raymond Wade, Rashmi Verma, Camilo Pena, Nattamol Hosiriluck
  International Reviews of Immunology. 2015-04-22

Journal Articles

• Cancer testis antigens:Potential new targets for lung cancer  
  MirandolaL., RiazJ., VermaR, Journal of Clinical Oncology
• Effect of galectin-3 inhibition on drug resistance, motility, invasion, and angiogenic potential in ovarian cancer  
  Verma R., Riaz J., alJournal of Clinical Oncology
• Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium  
  Mirandola L1, Wade R, Verma R, Pena C, Hosiriluck N, Figueroa JA, Cobos E, Jenkins MR, Chiriva-Internati M, Int Rev Immunol
• Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of Medicine.  
  Soape MP1, Verma R1, Payne JD1, Wachtel M1, Hardwicke F1, Cobos E1, Case Rep Gastrointest Med
• Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection  
  Lu C, Figueroa JA, Liu Z, Konala V, Aulakh A, Verma R, Cobos E, Chiriva-Internati M, Gao W1, Curr Cancer Drug Targets
• Effect of the novel galectin-3 blocker, Gal3M, on the efficacy and reduction of toxicity of proteosome inhibitors for the treatment of multiple myeloma  
  Riaz J., Verma R., Mirandola, Journal of Clinical Oncology
• Newer drugs, better treatment options come with a price  
  Mazek H., Verma R., Mohamed A., Ali E., Figueroa J., Journal of Investigative Medicine, 2015
• Cardiac toxicity with monoclonal antibodies therapy  
  Mazek H,Verma R, Southwest Respiratory and Critical Care Chronicles, 2015
• Splenules as masquerader of metastatic disease  
  Mazek H., Verma R., Cobos E.et al, Journal of Investigative Medicine, 2015
• .Fibromyoblastic tumor  
  Klomjit S., Verma R., Hosiriluck N., Mohamed A., Cobos E, Journal of Investigative Medicine, 2015
• T-cell Prolymphocytic Leukemia presenting as Skin Rash  
  Payne J., Verma R., Hardwicke F., Cobos E, Journal of Investigative Medicine, 2015
• Is it really malignancy? A case of chronic pancreatitis with vitamin D deficiency masquerading as malignancy  
  Mohamed A., Verma R., Mazek H., Tijani L., Rakvit A., Journal of Investigative Medicine, 2015
• Orbital pseudotumor  
  HosiriluckN., KlomjitS., VermaR., D'CunhaN., CobosE, Journal of Investigative Medicine, 2015
• The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review  
  Cobos C1, Figueroa JA, Mirandola L, Colombo M, Summers G, Figueroa A, Aulakh A, Konala V, Verma R, Riaz J, Wade R, Saadeh C, Rahman RL, Pandey A, Radhi S, Nguyen DD, J..., Int Rev Immunol, 2014
• MUC13 expression enhances colon cancer progression  
  Brij K. Gupta, Diane M. Maher, Mara Ebeling, Rashmi Verma, Douglas Lynch, Michael Koch, Akira Watanabe, Hiroyuki Aburatani, Meena Jaggi, and Subhash C. Chauhan, Cancer Research, 1/1/2011
• Join now to see all

Books/Book Chapters

• Biosimilars of Monoclonal Antibodies 
  Chapter: Therapeutic Monoclonal Antibodies and their targets - chapter 4: A Practical Guide to Manufacturing, Preclinical and Clinical Development in Biosimilars Book 
  Dr.Chiriva, Dr.Cobos,Dr.Verma2016

Abstracts/Posters

• Galectin 3C Inhibits Tumor Growth and Increases the Anticancer Activity of Taxol in vitro Murine Model of Ovarian Cancer
  Rashmi Verma, Texas Clinical Society San Antonio, San Antonio
• . Effect of the novel galectin-3 blocker, Gal3M, on the efficacy and reduction of toxicity of proteosome inhibitors for the treatment of multiple myeloma
  Riaz J., Verma R., Mirandola L et al, ASCO, e abstract
• Effect of galectin-3 inhibition on drug resistance, motility, invasion, and angiogenic potential in ovarian cancer.
  Verma R, Riaz J, ASCO, e abstract, 1/1/2014
• Cancer testis antigens: Potential new targets for lung cancer
  MirandolaL., RiazJ., VermaR, ASCO, e abstract, 2014
• MUC13 expression enhances colon cancer progression
  Brij K. Gupta, Diane M. Maher, Mara Ebeling, Rashmi Verma, AACR, 2011
• Join now to see all

Other

• Gender Specific Health-Breast Cancer,Laura W.Bush Institute for women's health 
  Verma rashmi
  http://www.sexandgenderhealth.org/
  Breast Cancer slide library - 1/1/2015
• Gender Specific Health-Lung Cancer,Laura W.Bush Institute for women's health 
  Nattamol, Verma R
  http://www.sexandgenderhealth.org/
  Lung Cancer slide library - 1/1/2015